The Future of Regulatory Affairs

Feb 11, 2020

Pratyusha Pallavi, Associate Director BU – Regulatory at ArisGlobal to Present “Automating Health Authority Correspondence and Commitments on a Unified Regulatory Platform”

MIAMI, FL Febuary 5, 2020 – ArisGlobal, ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 global life sciences companies,, announced that Pratyusha Pallavi, Associate Director BU – Regulatory at ArisGlobal will present at the DIA Regulatory Submissions, Information and Document Management Forum (RSIDM). She will present “Automating Health Authority Correspondence and Commitments on a Unified Regulatory Platform” on Tuesday, February 11, 2020, at the Bethesda North Marriott Hotel and Conference Center in North Bethesda, Maryland.

“Regulatory departments have to ensure that they build a RIM platform that is capable of embracing new technologies,” said Pratyusha. “RIMS need to improve data quality to meet the demands of other departments in addition to regulatory agencies, all while keeping the total cost of ownership under control. Now that artificial intelligence can identify our automatically determined regulatory filing requirements based on past applications and regulatory intelligence, this technology provides cost-effective opportunities that previously were not available in the regulatory environment.”

ArisGlobal will also be exhibiting at RSIDM in booth #312, showcasing LifeSphere Regulatory.

Learn more: For more on LifeSphere Regulatory, visit:

About DIA

DIA is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow.


About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn:
Follow @Aris_Global on Twitter:


Erika Thomas
+305-726-6601 |